| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |